APAC’s healthcare sector leading the charge for data, AI, predictive analytics and sustainability, but faces gaps in data and staffing, according to Philips Future Health Index 2022 report
APAC is well above the global average (82% vs 65%) in terms of healthcare leaders' recognition in the value of health data Investments in AI and predictive analytics are expected to increase 3 years from now, with top investment priorities in clinical use Over 80% of APAC healthcare leaders see predictive analytics having a positive impact on health...
Prolonging healthspan by delaying ageing — NUHS opens Singapore’s first Centre for Healthy Longevity to increase healthy lifespan of Singapore population by five more disease-free years
The National University Health System (NUHS) establishes the NUHS Centre for Healthy Longevity – a world's first integrated pre-clinical and clinical ageing research institute that is poised to lead the Longevity Medicine field with clinical research to prolong healthspan by delay ageing. The NUHS Centre for Healthy Longevity (NUHS CHL) will initiate, for the first time in a...
Sirnaomics to Present at 3rd Annual Jefferies Asia Forum
GAITHERSBURG, Md. and SUZHOU, China, Sept. 7, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that Dr. Patrick Lu, PhD, founder, Chairman of the Board, Executive Director, President, and CEO of Sirnaomics, will present at the 3rd Annual Jefferies Asia Forum that will be...
Non-invasive skin immune biomarker test helps predict development of eczema in babies, new study presented at the EADV Congress finds
MILAN, Sept. 7, 2022 /PRNewswire/ -- Researchers have identified an immune biomarker in newborns that can predict the subsequent onset and severity of paediatric atopic eczema, a new study presented at the 31st European Academy of Dermatology and Venereology (EADV) Congress has shown. The Barrier dysfunction in Atopic newBorns (BABY) study analysed a cohort of 450 babies (300 term...
FONDAZIONE PRADA PRESENTS “HUMAN BRAINS: PRESERVING THE BRAIN – FORUM ON NEURODEGENERATIVE DISEASES”
MILAN, Sept. 6, 2022 /PRNewswire/ -- "Human Brains" is the result of an in-depth research process undertaken by Fondazione Prada in 2018 in the field of neuroscience. The project has featured an online conference dedicated to the study of consciousness, a series of video talks by international scientists, philosophers and researchers, and an...
Hummingbird Bioscience to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
SAN FRANCISCO, Sept. 6, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced that Chief Executive Officer Piers Ingram, Ph.D., and Chief Financial Officer Josh House will participate in one-on-one investor meetings at Morgan Stanley's 20th Annual Global Healthcare Conference (September 12-14, 2022), held at the Sheraton...
Laekna Announces First Patient Dosed in South Korea in LAE201INT2101 Phase 1/2 Study
SHANGHAI and WARREN, N.J., Sept. 6, 2022 /PRNewswire/ -- Laekna, a clinical-stage biotechnology company dedicated to bringing ground-breaking therapies to cancer and liver fibrosis patients worldwide, announced yesterday that the first patient recently received a dose in the LAE201INT2101 phase I/II study at Seoul National University Hospital. The company's multi-regional clinical trials (MRCTs) now cover China, the United States...
Amcor reveals Lift-Off seed capital winners with investments that seek to “drive the revolution in packaging”
Global packaging leader to provide US $250,000 to two start-ups with cutting edge innovations for a more sustainable future for packaging ZURICH, Sept. 6, 2022 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, has announced the first batch of recipients for its ground-breaking Amcor Lift-Off seed funding initiative. Launched in April,...
Jacobio Receives CDE Approval for KRAS G12C Inhibitor JAB-218822’s Phase II Pivotal Study in China
BEIJING, SHANGHAI and BOSTON, Sept. 6, 2022 /PRNewswire/ -- Jacobio Pharma (1167.HK) has received Phase II pivotal study approval of KRAS G12C inhibitor JAB-21822 from the Center for Drug Evaluation (CDE) of China in September 5, 2022. This study aims to treat advanced or metastatic non-small cell lung cancer (NSCLC) with KRAS G12C mutation...
VISTA Eye Specialist Voted as a Winner of Reader’s Digest Most Trusted Brands Awards 2022 for Five Consecutive Years
PETALING JAYA, Malaysia, Sept. 6, 2022 /PRNewswire/ -- One of the largest eye specialist groups with 13 centers across Malaysia and growing, VISTA Eye Specialist (VISTA) once again proved their level of commitment, credibility, customer service, and impeccable consumers' trust by winning the Reader's Digest's Most Trusted Brands Awards 2022, this time emerging with Platinum in the Category of...
